IL6 and COVID-19: showed that in moderate to severe COVID‐19 patients, type I and III IFN responses were delayed and reduced compared to influenza patients, and instead, pro‐inflammatory cytokines such as IL‐6 and IL‐8 were produced first during COVID‐19, in contrast to the conventional kinetics of viral infections.